AIM
Income statement / Annual
Last year (2025), AIM ImmunoTech Inc's total revenue was $88.00 K,
a decrease of 48.24% from the previous year.
In 2025, AIM ImmunoTech Inc's net income was -$13.96 M.
See AIM ImmunoTech Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$88.00 K |
$170.00 K |
$202.00 K |
$141.00 K |
$135.00 K |
$163.00 K |
$140.00 K |
$367.00 K |
$437.00 K |
$92.00 K |
| Cost of Revenue |
$338.00 K
|
$31.00 K
|
$42.00 K
|
-$424.00 K
|
$850.00 K
|
$806.00 K
|
$893.00 K
|
$884.00 K
|
$1.18 M
|
$1.11 M
|
| Gross Profit |
-$250.00 K
|
$139.00 K
|
$160.00 K
|
$565.00 K
|
-$715.00 K
|
-$643.00 K
|
-$753.00 K
|
-$517.00 K
|
-$746.00 K
|
-$1.02 M
|
| Gross Profit Ratio |
-2.84
|
0.82
|
0.79
|
4.01
|
-5.3
|
-3.94
|
-5.38
|
-1.41
|
-1.71
|
-11.04
|
| Research and Development Expenses |
$3.92 M
|
$6.20 M
|
$10.93 M
|
$6.99 M
|
$7.67 M
|
$5.72 M
|
$4.65 M
|
$4.78 M
|
$4.10 M
|
$5.11 M
|
| General & Administrative Expenses |
$7.70 M
|
$13.71 M
|
$21.14 M
|
$13.07 M
|
$8.67 M
|
$8.65 M
|
$7.04 M
|
$6.20 M
|
$6.57 M
|
$7.68 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$339.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$7.70 M
|
$13.71 M
|
$21.14 M
|
$13.50 M
|
$8.67 M
|
$8.65 M
|
$7.04 M
|
$6.20 M
|
$6.57 M
|
$7.68 M
|
| Other Expenses |
-$1.35 M
|
$0.00
|
$14.00 K
|
$0.00
|
$1.78 M
|
$135.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$10.28 M
|
$19.91 M
|
$32.08 M
|
$20.49 M
|
$18.12 M
|
$14.51 M
|
$11.69 M
|
$10.98 M
|
$10.67 M
|
$12.79 M
|
| Cost And Expenses |
$10.61 M
|
$19.94 M
|
$32.12 M
|
$20.06 M
|
$18.97 M
|
$15.32 M
|
$12.58 M
|
$11.86 M
|
$11.85 M
|
$13.90 M
|
| Interest Income |
$3.18 M
|
$5.19 M
|
$1.07 M
|
$629.00 K
|
$0.00
|
$219.00 K
|
$89.00 K
|
$32.00 K
|
$88.00 K
|
$129.00 K
|
| Interest Expense |
$812.00 K
|
$585.00 K
|
$0.00
|
$0.00
|
$67.00 K
|
$672.00 K
|
$427.00 K
|
$502.00 K
|
$139.00 K
|
$0.00
|
| Depreciation & Amortization |
$210.00 K
|
$246.00 K
|
$238.00 K
|
-$424.00 K
|
$775.00 K
|
$733.00 K
|
$829.00 K
|
$920.00 K
|
$1.00 M
|
$1.17 M
|
| EBITDA |
-$10.32 M |
-$16.49 M |
-$28.72 M |
-$19.87 M |
-$18.29 M |
-$13.00 M |
-$8.15 M |
-$8.41 M |
-$7.12 M |
-$6.33 M |
| EBITDA Ratio |
-117.23
|
-96.99
|
-142.2
|
-140.91
|
-135.44
|
-79.72
|
-58.2
|
-22.9
|
-16.28
|
-68.84
|
| Operating Income Ratio |
-119.61
|
-116.31
|
-158
|
-141.3
|
-139.54
|
-92.96
|
-88.88
|
-31.32
|
-26.12
|
-150.04
|
| Total Other Income/Expenses Net |
-$3.43 M
|
$2.45 M
|
$2.95 M
|
$477.81 K
|
-$289.00 K
|
$752.00 K
|
$3.04 M
|
$1.67 M
|
$3.16 M
|
$6.30 M
|
| Income Before Tax |
-$13.96 M
|
-$17.32 M
|
-$28.96 M
|
-$19.45 M
|
-$19.13 M
|
-$14.40 M
|
-$9.40 M
|
-$9.81 M
|
-$8.26 M
|
-$7.50 M
|
| Income Before Tax Ratio |
-158.61
|
-101.88
|
-143.38
|
-137.91
|
-141.68
|
-88.34
|
-67.17
|
-26.74
|
-18.9
|
-81.54
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2.19 M
|
$0.00
|
$0.00
|
| Net Income |
-$13.96 M
|
-$17.32 M
|
-$28.96 M
|
-$19.45 M
|
-$19.13 M
|
-$14.40 M
|
-$9.40 M
|
-$9.81 M
|
-$8.26 M
|
-$7.50 M
|
| Net Income Ratio |
-158.61
|
-101.88
|
-143.38
|
-137.91
|
-141.68
|
-88.34
|
-67.17
|
-26.74
|
-18.9
|
-81.54
|
| EPS |
-8.62 |
-11.22396 |
-21.63843 |
-14.69061 |
-14.6652 |
-16.41486 |
-93.71208 |
-355.19187 |
-463.188 |
-543.048 |
| EPS Diluted |
-8.62 |
-11.22396 |
-21.63843 |
-14.69061 |
-14.6652 |
-16.41486 |
-93.71208 |
-355.19187 |
-463.188 |
-543.048 |
| Weighted Average Shares Out |
$1.62 M
|
$1.54 M
|
$1.34 M
|
$1.32 M
|
$1.31 M
|
$877.90 K
|
$100.43 K
|
$27.69 K
|
$17.97 K
|
$13.67 K
|
| Weighted Average Shares Out Diluted |
$1.62 M
|
$1.54 M
|
$1.34 M
|
$1.32 M
|
$1.31 M
|
$877.90 K
|
$100.43 K
|
$27.69 K
|
$17.97 K
|
$13.67 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
